skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Molecular dynamics analysis of the binding of human interleukin-6 with interleukin-6 α-receptor

Journal Article · · Proteins
DOI:https://doi.org/10.1002/prot.26002· OSTI ID:1785215
ORCiD logo [1];  [2];  [1];  [3]; ORCiD logo [1]
  1. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
  2. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Univ. of Tennessee, Knoxville, TN (United States)
  3. Univ. of Tennessee Health Science Center (UTHSC), Memphis, TN (United States)

Human interleukin-6 (hIL-6) is a multifunctional cytokine that regulates immune and inflammatory responses in addition to metabolic and regenerative processes and cancer. hIL-6 binding to the IL-6 receptor (IL-6Rα) induces homodimerization and recruitment of the glycoprotein (gp130) to form a hexameric signaling complex. Anti-IL-6 and IL-6R antibodies are clinically approved inhibitors of IL-6 signaling pathway for treating rheumatoid arthritis and Castleman's disease, respectively. There is a potential to develop novel small molecule IL-6 antagonists derived from understanding the structural basis for IL-6/IL-6Rα interactions. In this work, we combine homology modeling with extensive molecular dynamics (MD) simulations to examine the association of hIL-6 with IL-6Rα. A comparison with MD of apo hIL-6 reveals that the binding of hIL-6 to IL-6Rα induces structural and dynamic rearrangements in the AB loop region of hIL-6, disrupting intraprotein contacts and increasing the flexibility of residues 48 to 58 of the AB loop. In contrast, due to the involvement of residues 59 to 78 in forming contacts with the receptor, these residues of the AB loop are observed to rigidify in the presence of the receptor. The binary complex is primarily stabilized by two pairs of salt bridges, Arg181 (hIL-6)- Glu182 (IL-6Rα) and Arg184 (hIL-6)- Glu183 (IL-6Rα) as well as hydrophobic and aromatic stacking interactions mediated essentially by Phe residues in both proteins. An interplay of electrostatic, hydrophobic, hydrogen bonding, and aromatic stacking interactions facilitates the formation of the hIL-6/IL-6Rα complex.

Research Organization:
Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
1785215
Journal Information:
Proteins, Vol. 89, Issue 2; ISSN 0887-3585
Publisher:
WileyCopyright Statement
Country of Publication:
United States
Language:
English

References (56)

Simulation and Theory of Antibody Binding to Crowded Antigen-Covered Surfaces journal March 2016
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. journal May 1995
KFC2: A knowledge-based hot spot prediction method based on interface solvation, atomic density, and plasticity features: KFC2: A Knowledge-Based Hot Spot Prediction Method journal July 2011
Identification of a receptor binding site in the carboxyl terminus of human interleukin-6. journal July 1992
Structure-function analysis of human interleukin-6: Evidence for the involvement of the carboxy-terminus in function journal March 1990
An automated decision-tree approach to predicting protein interaction hot spots journal June 2007
Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor journal December 2011
CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data journal July 2013
Scalable molecular dynamics with NAMD journal January 2005
Molecular evolution of affinity and flexibility in the immune system journal May 2007
High-Resolution Comparative Modeling with RosettaCM journal October 2013
Characterizing the Diversity of the CDR-H3 Loop Conformational Ensembles in Relationship to Antibody Binding Properties journal January 2019
Structure-Function analysis of human IL-6: Identification of two distinct regions that are important for receptor binding journal December 1994
Molecular cloning and expression of an IL-6 signal transducer, gp130 journal December 1990
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses: Soluble gp130 inhibits transsignaling responses journal January 2001
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes journal March 1977
A hot spot of binding energy in a hormone-receptor interface journal January 1995
Molecular Description of Flexibility in an Antibody Combining Site journal May 2010
Comparison of simple potential functions for simulating liquid water journal July 1983
Re-epithelialization and immune cell behaviour in an ex vivo human skin model journal January 2020
The fundamental role of flexibility on the strength of molecular binding journal January 2012
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis journal July 2007
Constant pressure molecular dynamics simulation: The Langevin piston method journal September 1995
The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. journal April 1996
Conformational Flexibility of the MHC Class I α1-α2 Domain in Peptide Bound and Free States: A Molecular Dynamics Simulation Study journal October 2004
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES journal April 1997
Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study journal May 2015
1.9 Acrystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling journal March 1997
Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. journal April 1993
Involvement of the Arg179 in the active site of human IL-6 journal February 1993
CHARMM-GUI: A web-based graphical user interface for CHARMM journal March 2008
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial journal March 2008
Structure-activity relationship study of human interleukin-3: role of the C-terminal region for biological activity. journal August 1991
Hepcidin regulation in the anemia of inflammation journal January 2016
The pro- and anti-inflammatory properties of the cytokine interleukin-6 journal May 2011
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway1 journal September 1998
Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems journal June 1993
Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway journal June 2006
Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease journal June 2015
Interleukin-6 biology is coordinated by membrane bound and soluble receptors. journal September 2003
Analysis of the Human Interleukin-6/Human Interleukin-6 Receptor Binding Interface at the Amino Acid Level: Proposed Mechanism of Interaction journal February 1997
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis journal June 1989
Hexameric Structure and Assembly of the Interleukin-6/IL-6  -Receptor/gp130 Complex journal June 2003
Direct Determination of Vibrational Density of States Change on Ligand Binding to a Protein journal July 2004
Interleukin-6 family of cytokines and gp130 journal August 1995
Molecular Dynamics Simulations Reveal Key Roles of the Interleukin-6 Alpha Receptor in the Assembly of the Human Interleukin-6 Receptor Complex journal August 2017
Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies journal February 2018
Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor journal August 1988
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study journal March 2009
Considering new lessons about the use of IL-6 inhibitors in arthritis journal November 2018
Redistribution of Flexibility in Stabilizing Antibody Fragment Mutants Follows Le Châtelier’s Principle journal March 2014
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial journal March 2008
Small-Angle Neutron Scattering Study of a Monoclonal Antibody Using Free-Energy Constraints journal October 2013
Evidence for the importance of a positive charge and an α-helical structure of the C-terminus for biological activity of human IL-6 journal May 1991
VMD: Visual molecular dynamics journal February 1996
Rational design of a receptor super-antagonist of human interleukin-6. journal December 1994

Similar Records

Trans-signaling of interleukin-6 (IL-6) is mediated by the soluble IL-6 receptor, but not by soluble CD5
Journal Article · Sat Mar 18 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:1785215

Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein
Journal Article · Fri Jul 10 00:00:00 EDT 2009 · Proc. Natl. Acad. Sci. USA · OSTI ID:1785215

Structural Organization of a Full-Length Gp130/LIF-R Cytokine Receptor Transmembrane Complex
Journal Article · Tue May 26 00:00:00 EDT 2009 · Mol. Cell 31:737,2008 · OSTI ID:1785215